December 1, 2020 – CarepathRx announced a partnership with UPMC’s Chartwell subsidiary that will expand patient access to specialty pharmacy and home infusion services.
Under the agreement, CarepathRx will acquire the management services organization responsible for the operational and strategic management of Chartwell while UPMC becomes a strategic investor in CarepathRx. This new partnership expands CarepathRx’s specialty and home infusion capabilities, the company said.
CarepathRx was founded in 2019 by John Figueroa and middle market private equity firm Nautic Partners LLC. CarepathRx’s suite of solutions caters to patients undergoing specialty and infusion therapies, often for a variety of chronic conditions. CarepathRx works closely with partners across the health care spectrum—including health systems, community physicians, home health agencies and payors. CarepathRx delivers its services to more than 600 hospitals across the country.
The transaction is expected to close within 30 days. Terms of the agreement were not disclosed.